Cervicogenic Headache, Headache, Occipital Nerve Block, Pulsed Radiofrequency
Conditions
Keywords
Cervical pain, Visual Analog Scale, headache, interventional, pulsed radiofrequency treatment, secondary headache disorders, spinal nerves
Brief summary
The effect of GON PRF treatment applied with USG-guided proximal technique in patients who do not respond to conservative treatments for cervicogenic headache
Detailed description
In this study, GON PRF will be applied to paticipants who are diagnosed with cervicogenic headache according to ICHD-3 criteria, who meet the study criteria and who report a positive effect with diagnostic GON block application. The main purpose of the study is to evaluate the clinical efficacy and safety of ultrasound-guided C2 level greater occipital nerve pulsed radiofrequency treatment in cervicogenic headache during the follow-up period.Secondary purpose is to determine the effects of the GON PRF treatment applied on the volunteers' analgesic drug consumption, daily life activities and sleep, how they generally perceive this treatment and whether there is a need for any additional treatment.
Interventions
PROCEDUREGONPRF
GON PRF treatment, which we apply by imaging the target nerve and surrounding structures with the proximal technique (at C2 level) under USG guidance in patients who do not respond to conservative treatments for cervicogenic headache.
PROCEDUREProximal GONPRF
Ultrasound-guided pulsed radiofrequency treatment of the greater occipital nerve at the C2 level
Sponsors
Ankara City Hospital Bilkent
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Single-center, prospective, comparative, observational study
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed with cervicogenic headache according to ICHD-3 criteria * Cranial and cervical spine imaging is available * Number of headache days per month 5 and/or more * Inadequate benefit from pharmacological treatments or physical therapy methods used * Volunteer patients who can understand and approve the treatment and the informed consent form and who can comply with the treatment
Exclusion criteria
* History of secondary headache other than cervicogenic headache according to ICHD-3 criteria * Cervical nerve root irritation and/or spinal stenosis symptoms and signs * Sensory deficit findings in the greater occipital nerve dermatome * Craniocervical defect or other anatomical abnormality in the target area or nearby the procedure * Local or systemic infection * Received nonpharmacological treatment within the last 3 months (physical therapy, botulinum toxin A, acupuncture, ozone, cognitive behavioral therapy, etc.) * Pregnancy or suspected pregnancy * Known allergy to local anesthetic drugs * History of malignancy * Known organic disease of the brain and spinal cord * History of cranial/cervical surgery within the last 1 year * Bleeding-clotting disorder or oral anticoagulant use * Comorbid disease that may cause headache (uncontrolled hypertension, intracranial lesion, etc.) * Compliance with treatment and treatment results diseases that may affect the evaluation (psychiatric disorder, dementia, etc.) * Those who request re-treatment due to the emergence of contralateral pain or other types of pain during the follow-up period after treatment * Those who do not accept treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale | 3 months | Average headache severity, maximum headache severity, number of headache days (monthly) measured with a visual analog scale (VAS; 10-point VAS scoring, 0 being no pain and 10 being the highest pain intensity that can be tolerated) |
Countries
Turkey (Türkiye)
Outcome results
None listed